203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

Aberrant thymic architecture and enhanced interferon signaling in down syndrome

MEFV E148Q P369S R408Q germ line variant identified from the adolescent imcd tafro family conferred severe disease manifestations in a cohort of 37 patients with castleman disease

Epidemiology and clinical characteristics of idiopathic multicentric castleman disease in Spain ARCANA study Prevalence cohort

Lipid metabolism disorders and immune metabolic programming in patients with idiopathic multicentric Castleman disease

Knockdown of the long isoform of the prolactin receptor selectively targets pathogenic immune cells and averts lupus nephritis

Automated grading of castleman disease histopathology using an attention based multiple instance learning model

Comprehensive analysis of subtype specific outcomes and management in castleman disease A 20 year cohort Study

Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab